Dateline City: DURHAM, N.C. Positive Real-World Data From Tryton Stent System Presented at Joint Interventional Meeting in Rome DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced that more than 4000 patients have been treated with the company’s Tryton™ Side Branch Stent in Europe, Russia and the Middle East. New data …

Dateline City: DURHAM, N.C. New Code Signals Growing Market Acceptance for Side Branch Stents DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, announced that the German Institute for Medical Documentation and Information (DIMDI, Cologne) has revised the procedure code for the treatment of coronary bifurcations lesions, distinguishing dedicated side branch stent systems …

Dateline City: DURHAM, N.C. More Than 175 Patients Enrolled in Multi-National Pivotal Trial DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical, Inc., the leading developer of stents designed to definitively treat bifurcation lesions, today announced completion of patient enrollment in the intravascular ultrasound (IVUS) cohort of the randomized, controlled Tryton IDE Study evaluating the TRYTON Side Branch Stent for the treatment of bifurcation disease. …

Dateline City: DURHAM, N.C. DURHAM, N.C.–(BUSINESS WIRE)–Tryton Medical’s TRYTON Side Branch Stent™ System was discussed as an important new therapeutic option for patients with bifurcation disease last week at the annual European Bifurcation Club (EBC) meeting in Lisbon, Portugal, where approximately 150 international interventional cardiologists gathered to share best practices for challenging bifurcation cases. Patrick W. Serruys, M.D., Ph.D., of …